Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Unravelling CD24 ‐ Siglec‐10 pathway: Cancer immunotherapy from basic science to clinical studies

11 Aug 2024

Abstract excerpt

Cancer immunotherapy has revolutionized the treatment landscape by harnessing the power of the immune system to combat malignancies. Two of the most promising players in this field are cluster of differentiation 24 (CD24) and sialic acid-binding Ig-like lectin 10 (Siglec-10), and both of them play pivotal roles in modulating immune responses. CD24, a cell surface glycoprotein, emerges as a convincing fundamental...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Immune cells in cancer
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39129256
DOI: 10.1111/imm.13847

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Unravelling CD24 ‐ Siglec‐10 pathway: Cancer immunotherapy from basic science to clinical studiesPMID 39129256Read ↗

Novel insights into the function of CD24 : A driving force in cancerSemantic proximity Read ↗

Surprising magic of CD24 beyond cancerSemantic proximity Read ↗

Immunosuppressive Signaling Pathways as Targeted Cancer TherapiesSemantic proximity Read ↗

Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer TypesSemantic proximity Read ↗

Leveraging NKG2D Ligands in Immuno-OncologySemantic proximity Read ↗

Elucidating tumor immunosurveillance and immunoediting: a comprehensive reviewSemantic proximity Read ↗

Tumor Derived SIGLEC Family Genes May Play Roles in Tumor Genesis, Progression, and Immune Microenvironment RegulationSemantic proximity Read ↗

Overview of CD24 as a new molecular marker in ovarian cancerSemantic proximity Read ↗

A mechanistic, functional, and clinical perspective on targeting CD70 in cancerSemantic proximity Read ↗

Immunobiology and Conflicting Roles of the Human NKG2D Lymphocyte Receptor and Its Ligands in CancerSemantic proximity Read ↗

Unraveling the glyco-immunity nexus in pancreatic cancerSemantic proximity Read ↗

VISTA: A Promising Target for Cancer Immunotherapy?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.